Loading chat...
GA SB376
Bill
Status
Introduced
2/7/2020
Primary Sponsor
Jennifer Jordan
Click for details
AI Summary
- Caps the total cost-sharing amount a covered person must pay for prescription insulin at $100.00 per 30-day supply, regardless of the amount or type of insulin needed to fill the prescription
- Applies to all health care insurers offering coverage for prescription insulin drugs, including accident and sickness insurers, health care corporations, health maintenance organizations, and provider-sponsored health care corporations
- Cost-sharing includes deductibles, coinsurance, copayments, and similar charges but excludes premium payments; insurers are permitted to set cost-sharing below the $100.00 cap
- Legislative findings cite significantly rising insulin prices and that one in four diabetics have reported insulin underuse due to high costs
- Effective January 1, 2021, applying to all policies issued, delivered, issued for delivery, or renewed in Georgia on or after that date
Legislative Description
Insurance; out-of-pocket cost of consumers requiring insulin; reduce
Last Action
Senate Read and Referred
2/18/2020
Full Bill Text
No bill text available